The invention relates to a
traditional Chinese medicine prescription for treating pulmonary diseases, which comprises lapis chloriti, roasted ephedra, almond,
schisandra, snakegourd peel and roasted licorice. Experiments prove that the
traditional Chinese medicine prescription can obviously improve the pulmonary
lesion and inflammatory reaction of a model rat with the chronic obstructive
pulmonary disease at the acute
exacerbation, so as to obviously reduce the contents of main inflammatory markers in the serum of the model rat, and simultaneously can promote the trachea repair of the model rat so as to prevent the occurrence and development of trachea
inflammation. Clinical researches show that the
traditional Chinese medicine prescription has a good effect and a high effect taking speed when being used for treating empirical pulmonary diseases, such as accumulation of pathogenic heat in the
lung and obstruction of the
lung by
phlegm; the good effect can be achieved within 3-10 days, and the total effective rate reaches 96.6%; the traditional Chinese
medicine prescription especially has good curative effects on chronic intractable pulmonary diseases induced by pathogenic heat and stubborn
phlegm; the traditional Chinese
medicine prescription does not have toxic or side effects; and the pulmonary diseases can not recur.